Published in Cancer Weekly, August 6th, 2002
Drs. Dave Bates and Steve Harper in the Microvascular Research Laboratories in the department of physiology, working in collaboration with clinicians at Southmead Hospital, have discovered a type of vascular endothelial growth factor (VEGF) found in normal kidneys that has a different structure from that found in kidney cancer. The research findings was published in Cancer Research.
This new form of VEGF, VEGF165b, has a different structure at the end of the molecule and is switched off in kidney cancer. It also seems to be able to inhibit at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-08-06)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.